The Return to FDA: Politics, Regulation, and Controversy

This chapter examines the return of a key figure to the FDA after a tumultuous departure, focusing on its impact on vaccine and gene therapy regulation. It addresses the political forces at play and the potential challenges the FDA faces in maintaining scientific integrity amid external pressures.